Increased protein<i>O</i>-GlcNAc modification inhibits inflammatory and neointimal responses to acute endoluminal arterial injury
Dongqi Xing(University of Alabama at Birmingham), Suzanne Oparil(University of Alabama at Birmingham), Yiu-Fai Chen(University of Alabama at Birmingham), László G. Nöt, Erum Majid-Hassan, Yun Zhang(Chinese Academy of Medical Sciences & Peking Union Medical College), Wenguang Feng(University of Alabama at Birmingham), Andrew P. Miller(University of Alabama at Birmingham), John C. Chatham(University of Alabama at Birmingham)
American Journal of Physiology-Heart and Circulatory Physiology
May 10, 2008
Cited by 102
Related Papers
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol
|The Lancet|2002|5.4k
A Controlled Trial of Renal Denervation for Resistant Hypertension
|New England Journal of Medicine|2014|2.2k